SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'DRK'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DLS_A_MTXA188_1 (DIHYDROFOLATEREDUCTASE) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 12 | ILE A 162SER A 227ILE A 167ASN A 171LEU A 183 | NoneNoneNoneDRK A 384 ( 4.6A)None | 1.02A | 1dlsA-3eb0A:undetectable | 1dlsA-3eb0A:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | LEU A 15GLY A 16VAL A 23ALA A 36LEU A 173TYR A 119 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A) | 1.39A | 1muoA-3eb0A:18.7 | 1muoA-3eb0A:26.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | LEU A 15GLY A 16VAL A 23ALA A 36TYR A 119LEU A 173 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.99A | 1muoA-3eb0A:18.7 | 1muoA-3eb0A:26.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MZ9_A_VDYA1002_3 (CARTILAGE OLIGOMERICMATRIX PROTEIN) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 5 | ILE A 168LEU A 167VAL A 132ALA A 276 | DRK A 1 ( 4.2A)NoneNoneNone | 0.95A | 1mz9C-3f3zA:undetectable | 1mz9C-3f3zA:12.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 6 | ILE A 34VAL A 42ILE A 85ASP A 169 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)NoneNone | 0.74A | 1uwhA-3f3zA:14.7 | 1uwhA-3f3zA:23.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_B_BAXB1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 6 | ILE A 34VAL A 42ILE A 85ASP A 169 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)NoneNone | 0.74A | 1uwhB-3f3zA:8.7 | 1uwhB-3f3zA:23.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XKK_A_FMMA91_2 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 9 | VAL A 42LYS A 57LEU A 88LEU A 100LEU A 104 | DRK A 1 ( 4.9A)DRK A 1 (-4.1A)NoneNoneDRK A 1 (-4.4A) | 0.54A | 1xkkA-3f3zA:22.2 | 1xkkA-3f3zA:24.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_B_MIXB1539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15GLY A 16VAL A 23ALA A 36TYR A 119ASN A 171ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)DRK A 384 (-4.4A)DRK A 384 ( 4.6A)DRK A 384 ( 4.7A) | 1.02A | 2fumB-3eb0A:25.4 | 2fumB-3eb0A:27.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_B_MIXB1539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15VAL A 23ALA A 36MET A 117TYR A 119ASN A 171ASP A 185 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 ( 4.6A)DRK A 384 ( 4.7A) | 0.89A | 2fumB-3eb0A:25.4 | 2fumB-3eb0A:27.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15GLY A 16GLY A 18VAL A 23ALA A 36MET A 117ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneNoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 ( 4.7A) | 0.88A | 2fumD-3eb0A:17.4 | 2fumD-3eb0A:27.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15GLY A 16VAL A 23ALA A 36MET A 117LYS A 168ASN A 171ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)NoneDRK A 384 ( 4.6A)DRK A 384 ( 4.7A) | 0.89A | 2fumD-3eb0A:17.4 | 2fumD-3eb0A:27.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15VAL A 23ALA A 36MET A 117THR A 123LYS A 168ASN A 171ASP A 185 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 ( 4.5A)NoneDRK A 384 ( 4.6A)DRK A 384 ( 4.7A) | 1.00A | 2fumD-3eb0A:17.4 | 2fumD-3eb0A:27.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IVU_A_ZD6A3015_0 (PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RETPRECURSOR) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15GLY A 16VAL A 23LYS A 38GLU A 50TYR A 119 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneNoneNoneDRK A 384 (-4.4A) | 0.49A | 2ivuA-3eb0A:23.3 | 2ivuA-3eb0A:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OIQ_A_STIA1001_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36LYS A 38GLU A 50MET A 54TYR A 119LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.75A | 2oiqA-3eb0A:21.8 | 2oiqA-3eb0A:23.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PL0_A_STIA200_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36LYS A 38GLU A 50MET A 54TYR A 119LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.93A | 2pl0A-3eb0A:20.8 | 2pl0A-3eb0A:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_A_B49A1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 8 / 12 | ILE A 34VAL A 42ALA A 55ILE A 86LEU A 104GLY A 108GLU A 109LEU A 155 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.6A) | 0.82A | 2y7jA-3f3zA:30.1 | 2y7jA-3f3zA:27.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_B_B49B1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 10 | ILE A 34VAL A 42ALA A 55ILE A 86LEU A 104LEU A 155 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A)DRK A 1 (-4.6A) | 0.59A | 2y7jB-3f3zA:35.0 | 2y7jB-3f3zA:27.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_C_B49C1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 10 | ILE A 34VAL A 42ALA A 55ILE A 86LEU A 104LEU A 155 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A)DRK A 1 (-4.6A) | 0.60A | 2y7jC-3f3zA:30.4 | 2y7jC-3f3zA:27.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_D_B49D1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 10 | ILE A 34VAL A 42ALA A 55ILE A 86LEU A 104LEU A 155 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A)DRK A 1 (-4.6A) | 0.63A | 2y7jD-3f3zA:30.4 | 2y7jD-3f3zA:27.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CS9_D_NILD600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 6 | LEU A 15VAL A 23LYS A 38LEU A 173 | DRK A 384 (-3.8A)NoneNoneDRK A 384 (-4.4A) | 0.38A | 3cs9D-3eb0A:20.6 | 3cs9D-3eb0A:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUP_A_MI1A1_1 (TYROSINE-PROTEINKINASE JAK2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15GLY A 16GLY A 18GLY A 21VAL A 23ALA A 36MET A 117TYR A 119 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneNoneNoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 (-4.4A) | 0.73A | 3fupA-3eb0A:23.7 | 3fupA-3eb0A:26.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUP_A_MI1A1_1 (TYROSINE-PROTEINKINASE JAK2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15GLY A 16VAL A 23ALA A 36LYS A 38MET A 117TYR A 119ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)NoneDRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.75A | 3fupA-3eb0A:23.7 | 3fupA-3eb0A:26.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUP_B_MI1B1_1 (TYROSINE-PROTEINKINASE JAK2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15GLY A 16GLY A 18ALA A 36LYS A 38MET A 117TYR A 119ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)NoneDRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.81A | 3fupB-3eb0A:23.7 | 3fupB-3eb0A:26.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GVU_A_STIA1001_1 (TYROSINE-PROTEINKINASE ABL2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.73A | 3gvuA-3eb0A:21.3 | 3gvuA-3eb0A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LFA_A_1N1A361_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 8 | ALA A 55LYS A 57LEU A 100LEU A 104 | DRK A 1 (-3.4A)DRK A 1 (-4.1A)NoneDRK A 1 (-4.4A) | 0.34A | 3lfaA-3f3zA:19.3 | 3lfaA-3f3zA:28.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXK_A_MI1A1125_1 (TYROSINE-PROTEINKINASE JAK3) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15GLY A 16VAL A 23ALA A 36LYS A 38MET A 117TYR A 119ASP A 185 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneDRK A 384 (-3.5A)NoneDRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.93A | 3lxkA-3eb0A:23.5 | 3lxkA-3eb0A:24.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXK_A_MI1A1125_1 (TYROSINE-PROTEINKINASE JAK3) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38MET A 117TYR A 119LEU A 173ASP A 185 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneDRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.96A | 3lxkA-3eb0A:23.5 | 3lxkA-3eb0A:24.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXN_A_MI1A1_1 (NON-RECEPTORTYROSINE-PROTEINKINASE TYK2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38ILE A 63TYR A 119LEU A 173ASP A 185 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.79A | 3lxnA-3eb0A:23.6 | 3lxnA-3eb0A:26.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MS9_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.65A | 3ms9A-3eb0A:20.9 | 3ms9A-3eb0A:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MSS_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.64A | 3mssA-3eb0A:21.0 | 3mssA-3eb0A:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MSS_C_STIC1_1 (TYROSINE-PROTEINKINASE ABL1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.63A | 3mssC-3eb0A:21.0 | 3mssC-3eb0A:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OG7_A_032A1_1 (AKAP9-BRAF FUSIONPROTEIN) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 12 | ILE A 34VAL A 42ALA A 55LYS A 57CYH A 105PHE A 170 | DRK A 1 (-4.2A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 (-4.1A)None | 1.02A | 3og7A-3f3zA:18.2 | 3og7A-3f3zA:25.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PYY_A_STIA3_1 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.71A | 3pyyA-3eb0A:21.4 | 3pyyA-3eb0A:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PYY_B_STIB4_1 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.73A | 3pyyB-3eb0A:21.3 | 3pyyB-3eb0A:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V5W_A_8PRA701_1 (G-PROTEIN COUPLEDRECEPTOR KINASE 2) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 7 / 12 | ILE A 34GLY A 37GLY A 40VAL A 42ALA A 55LYS A 57LEU A 155 | DRK A 1 (-4.2A)NoneNoneDRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 (-4.6A) | 0.58A | 3v5wA-3f3zA:10.8 | 3v5wA-3f3zA:17.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WAR_A_NIOA401_1 (CASEIN KINASE IISUBUNIT ALPHA) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 8 | VAL A 42LYS A 57ILE A 86ILE A 168 | DRK A 1 ( 4.9A)DRK A 1 (-4.1A)DRK A 1 ( 4.8A)DRK A 1 ( 4.2A) | 0.55A | 3warA-3f3zA:26.5 | 3warA-3f3zA:26.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | ILE A 53MET A 54LEU A 57ILE A 62ILE A 63TYR A 119 | NoneNoneNoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.56A | 3zosA-3eb0A:21.1 | 3zosA-3eb0A:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | LEU A 15ILE A 53MET A 54LEU A 57ILE A 62TYR A 119 | DRK A 384 (-3.8A)NoneNoneNoneNoneDRK A 384 (-4.4A) | 0.50A | 3zosB-3eb0A:21.0 | 3zosB-3eb0A:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AG8_A_AXIA2000_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50LEU A 173CYH A 184 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A)DRK A 384 ( 3.8A) | 0.68A | 4ag8A-3eb0A:21.0 | 4ag8A-3eb0A:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36GLU A 50ILE A 53MET A 54ILE A 63LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.64A | 4bkjA-3eb0A:20.8 | 4bkjA-3eb0A:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36GLU A 50ILE A 53MET A 54TYR A 119LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.81A | 4bkjA-3eb0A:20.8 | 4bkjA-3eb0A:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36GLU A 50ILE A 53MET A 54ILE A 63LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.78A | 4bkjB-3eb0A:20.9 | 4bkjB-3eb0A:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CKI_A_ADNA2022_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 11 | LEU A 15GLY A 16GLY A 18VAL A 23ALA A 36TYR A 119 | DRK A 384 (-3.8A)DRK A 384 ( 4.4A)NoneNoneDRK A 384 (-3.5A)DRK A 384 (-4.4A) | 0.81A | 4ckiA-3eb0A:23.7 | 4ckiA-3eb0A:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CSV_A_STIA1265_1 (SRC-ABL TYROSINEKINASE ANCESTOR) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | VAL A 23ALA A 36GLU A 50ILE A 53MET A 54TYR A 119LEU A 173 | NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.72A | 4csvA-3eb0A:22.3 | 4csvA-3eb0A:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GH8_A_MTXA201_1 (DIHYDROFOLATEREDUCTASE) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 12 | ILE A 162SER A 227ILE A 167ASN A 171LEU A 183 | NoneNoneNoneDRK A 384 ( 4.6A)None | 0.83A | 4gh8A-3eb0A:undetectable | 4gh8A-3eb0A:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IAA_A_RTZA401_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 11 | VAL A 42ALA A 55LYS A 57LEU A 155ILE A 168ASP A 169 | DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 (-4.6A)DRK A 1 ( 4.2A)None | 0.96A | 4iaaA-3f3zA:21.9 | 4iaaA-3f3zA:28.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 7 / 12 | GLY A 35VAL A 42ALA A 55LEU A 88LEU A 100GLY A 108ILE A 168 | DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)NoneNoneDRK A 1 ( 4.9A)DRK A 1 ( 4.2A) | 0.56A | 4ifgA-3f3zA:29.5 | 4ifgA-3f3zA:26.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 7 / 12 | GLY A 35VAL A 42ALA A 55LYS A 57LEU A 100GLY A 108ILE A 168 | DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)NoneDRK A 1 ( 4.9A)DRK A 1 ( 4.2A) | 0.64A | 4ifgA-3f3zA:29.5 | 4ifgA-3f3zA:26.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 8 / 12 | VAL A 42ALA A 55LEU A 88LEU A 100GLY A 108GLU A 109LEU A 155ILE A 168 | DRK A 1 ( 4.9A)DRK A 1 (-3.4A)NoneNoneDRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.6A)DRK A 1 ( 4.2A) | 0.53A | 4ifgA-3f3zA:29.5 | 4ifgA-3f3zA:26.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 7 / 12 | VAL A 42ALA A 55LYS A 57LEU A 100GLY A 108LEU A 155ILE A 168 | DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)NoneDRK A 1 ( 4.9A)DRK A 1 (-4.6A)DRK A 1 ( 4.2A) | 0.58A | 4ifgA-3f3zA:29.5 | 4ifgA-3f3zA:26.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L9I_A_8PRA601_1 (RHODOPSIN KINASE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 7 | VAL A 42ALA A 55MET A 102LEU A 155 | DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-3.6A)DRK A 1 (-4.6A) | 0.44A | 4l9iA-3f3zA:25.1 | 4l9iA-3f3zA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L9I_B_8PRB601_1 (RHODOPSIN KINASE) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 8 | GLY A 18VAL A 23ALA A 36LYS A 38MET A 117 | NoneNoneDRK A 384 (-3.5A)NoneDRK A 384 (-3.8A) | 0.57A | 4l9iB-3eb0A:24.3 | 4l9iB-3eb0A:23.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L9I_B_8PRB601_1 (RHODOPSIN KINASE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 8 | GLY A 37VAL A 42ALA A 55LYS A 57MET A 102LEU A 155 | NoneDRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 (-3.6A)DRK A 1 (-4.6A) | 0.86A | 4l9iB-3f3zA:22.1 | 4l9iB-3f3zA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MXO_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50MET A 54TYR A 119 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A) | 0.64A | 4mxoA-3eb0A:23.1 | 4mxoA-3eb0A:23.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0U_A_ADNA501_1 (AURORA KINASE A) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 6 | VAL A 23ALA A 36THR A 123LEU A 173 | NoneDRK A 384 (-3.5A)DRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.64A | 4o0uA-3eb0A:19.4 | 4o0uA-3eb0A:26.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0W_A_ADNA501_1 (AURORA KINASE A) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 6 | LEU A 15VAL A 23ALA A 36THR A 123LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)DRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.81A | 4o0wA-3eb0A:25.7 | 4o0wA-3eb0A:26.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OGR_A_ADNA401_1 (CYCLIN-DEPENDENTKINASE 9) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 8 | VAL A 23ALA A 36ASN A 171LEU A 173ASP A 185 | NoneDRK A 384 (-3.5A)DRK A 384 ( 4.6A)DRK A 384 (-4.4A)DRK A 384 ( 4.7A) | 0.59A | 4ogrA-3eb0A:30.0 | 4ogrA-3eb0A:28.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMZ_A_B49A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 12 | ILE A 34GLY A 35VAL A 42ALA A 55MET A 102LEU A 155 | DRK A 1 (-4.2A)DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-3.6A)DRK A 1 (-4.6A) | 0.67A | 4qmzA-3f3zA:22.8 | 4qmzA-3f3zA:27.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 7 / 12 | VAL A 42ALA A 55LYS A 57MET A 77CYH A 105LEU A 155ASP A 169 | DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)NoneDRK A 1 (-4.1A)DRK A 1 (-4.6A)None | 0.77A | 4r7iA-3f3zA:21.7 | 4r7iA-3f3zA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZ7_A_1E8A901_1 (CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 6 / 10 | ILE A 34ALA A 55LYS A 57ILE A 86LEU A 104LEU A 155 | DRK A 1 (-4.2A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A)DRK A 1 (-4.6A) | 0.52A | 4rz7A-3f3zA:11.3 | 4rz7A-3f3zA:14.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TYJ_A_0LIA801_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 6 | LEU A 15VAL A 23LYS A 38ILE A 62 | DRK A 384 (-3.8A)NoneNoneNone | 0.63A | 4tyjA-3eb0A:21.2 | 4tyjA-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U0I_A_0LIA1001_1 (MAST/STEM CELLGROWTH FACTORRECEPTORKIT,MAST/STEM CELLGROWTH FACTORRECEPTOR KIT) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 10 | LEU A 15VAL A 23GLU A 50ILE A 62VAL A 115TYR A 119 | DRK A 384 (-3.8A)NoneNoneNoneNoneDRK A 384 (-4.4A) | 0.60A | 4u0iA-3eb0A:20.9 | 4u0iA-3eb0A:24.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 7 | VAL A 23LYS A 38MET A 54ILE A 63 | NoneNoneNoneDRK A 384 ( 4.5A) | 0.73A | 4uxqA-3eb0A:21.0 | 4uxqA-3eb0A:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_A_0LIA1776_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | LEU A 15VAL A 23LYS A 38ILE A 63TYR A 119ILE A 62 | DRK A 384 (-3.8A)NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)None | 1.17A | 4v01A-3eb0A:20.3 | 4v01A-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_A_0LIA1776_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 9 | LEU A 15VAL A 23LYS A 38ILE A 63TYR A 119LEU A 173 | DRK A 384 (-3.8A)NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.80A | 4v01A-3eb0A:20.3 | 4v01A-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_B_0LIB1770_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 9 | LEU A 15VAL A 23LYS A 38ILE A 63TYR A 119LEU A 173ILE A 62 | DRK A 384 (-3.8A)NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A)None | 1.43A | 4v01B-3eb0A:20.8 | 4v01B-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_A_0LIA1772_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 8 | LYS A 38MET A 54ILE A 63LEU A 173 | NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.67A | 4v04A-3eb0A:20.4 | 4v04A-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_A_0LIA1772_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 8 | LYS A 38MET A 54ILE A 63TYR A 119 | NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.70A | 4v04A-3eb0A:20.4 | 4v04A-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_B_0LIB1771_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 10 | LEU A 15VAL A 23LYS A 38ILE A 63TYR A 119LEU A 173ILE A 62 | DRK A 384 (-3.8A)NoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A)None | 1.24A | 4v04B-3eb0A:20.8 | 4v04B-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_B_0LIB1771_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 10 | LEU A 15VAL A 23LYS A 38MET A 54ILE A 63TYR A 119LEU A 173 | DRK A 384 (-3.8A)NoneNoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.82A | 4v04B-3eb0A:20.8 | 4v04B-3eb0A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WBO_B_ANWB601_0 (RHODOPSIN KINASE) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 8 | LEU A 15ALA A 36MET A 117LEU A 173 | DRK A 384 (-3.8A)DRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 (-4.4A) | 0.67A | 4wboB-3eb0A:24.3 | 4wboB-3eb0A:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WBO_C_ANWC601_0 (RHODOPSIN KINASE) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 6 | LEU A 15ALA A 36MET A 117LEU A 173 | DRK A 384 (-3.8A)DRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 (-4.4A) | 0.67A | 4wboC-3eb0A:24.5 | 4wboC-3eb0A:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50MET A 54ILE A 63LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 ( 4.5A)DRK A 384 (-4.4A) | 0.71A | 5bvwA-3eb0A:12.3 | 5bvwA-3eb0A:24.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 8 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50MET A 54TYR A 119LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.83A | 5bvwA-3eb0A:12.3 | 5bvwA-3eb0A:24.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_A_032A401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | ALA A 36ILE A 63TYR A 119CYH A 184PHE A 186GLY A 187 | DRK A 384 (-3.5A)DRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 ( 3.8A)NoneNone | 1.09A | 5hesA-3eb0A:5.8 | 5hesA-3eb0A:26.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_A_032A401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | VAL A 23ALA A 36ILE A 63TYR A 119CYH A 184PHE A 186 | NoneDRK A 384 (-3.5A)DRK A 384 ( 4.5A)DRK A 384 (-4.4A)DRK A 384 ( 3.8A)None | 1.02A | 5hesA-3eb0A:5.8 | 5hesA-3eb0A:26.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_2 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 7 | GLY A 16LEU A 65ASP A 185PHE A 186 | DRK A 384 ( 4.4A)NoneDRK A 384 ( 4.7A)None | 0.82A | 5hieB-3eb0A:6.6 | 5hieB-3eb0A:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_2 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 7 | GLY A 37CYH A 105ASP A 169PHE A 170 | NoneDRK A 1 (-4.1A)NoneNone | 0.84A | 5hieB-3f3zA:23.1 | 5hieB-3f3zA:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_D_P06D801_2 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 8 | GLY A 37CYH A 105ASP A 169PHE A 170 | NoneDRK A 1 (-4.1A)NoneNone | 0.86A | 5hieD-3f3zA:23.3 | 5hieD-3f3zA:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IGZ_A_SPRA404_2 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 9 | LEU A 172ILE A 228ILE A 62GLU A 118VAL A 120 | NoneNoneNoneNoneDRK A 384 (-4.5A) | 1.42A | 5igzA-3eb0A:7.5 | 5igzA-3eb0A:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IZJ_F_AZ1F2_1 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA47P-AZ1-DAR-DAR-DAR) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 7 | GLY A 35GLY A 37SER A 38GLY A 40VAL A 42 | DRK A 1 ( 3.9A)NoneNoneNoneDRK A 1 ( 4.9A) | 0.76A | 5izjB-3f3zA:30.0 | 5izjB-3f3zA:28.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_B_ADNB401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 9 | GLY A 35VAL A 42ALA A 55ILE A 86MET A 102 | DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-3.6A) | 0.64A | 5lw1B-3f3zA:23.1 | 5lw1B-3f3zA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_B_ADNB401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 9 | ILE A 34GLY A 35VAL A 42ALA A 55ILE A 86 | DRK A 1 (-4.2A)DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A) | 0.47A | 5lw1B-3f3zA:23.1 | 5lw1B-3f3zA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_E_ADNE401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 10 | GLY A 35VAL A 42ALA A 55ILE A 86LEU A 104 | DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-4.4A) | 0.38A | 5lw1E-3f3zA:22.8 | 5lw1E-3f3zA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_E_ADNE401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 5 / 10 | GLY A 35VAL A 42ALA A 55ILE A 86MET A 102 | DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.8A)DRK A 1 (-3.6A) | 0.69A | 5lw1E-3f3zA:22.8 | 5lw1E-3f3zA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MAF_A_XINA403_1 (MATERNAL EMBRYONICLEUCINE ZIPPERKINASE) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 8 / 12 | ILE A 34GLY A 35VAL A 42ALA A 55LYS A 57GLY A 108GLU A 109ILE A 168 | DRK A 1 (-4.2A)DRK A 1 ( 3.9A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 ( 4.9A)DRK A 1 (-3.4A)DRK A 1 ( 4.2A) | 0.59A | 5mafA-3f3zA:30.8 | 5mafA-3f3zA:14.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N3H_A_NCAA401_0 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 10 | LEU A 15VAL A 23ALA A 36MET A 117TYR A 119LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)DRK A 384 (-3.8A)DRK A 384 (-4.4A)DRK A 384 (-4.4A) | 0.70A | 5n3hA-3eb0A:25.7 | 5n3hA-3eb0A:25.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OWR_A_1N1A401_1 (SERINE/THREONINE-PROTEIN KINASE 10) |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 8 | ALA A 55CYH A 105LEU A 155ASP A 169 | DRK A 1 (-3.4A)DRK A 1 (-4.1A)DRK A 1 (-4.6A)None | 0.72A | 5owrA-3f3zA:23.8 | 5owrA-3f3zA:27.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE0_A_XINA401_2 (AP2-ASSOCIATEDPROTEIN KINASE 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 4 / 5 | LEU A 15VAL A 23MET A 117CYH A 184 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.8A)DRK A 384 ( 3.8A) | 0.74A | 5te0A-3eb0A:24.1 | 5te0A-3eb0A:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YF9_X_NIOX401_1 (CASEIN KINASE IISUBUNIT ALPHA') |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 5 / 9 | LEU A 15VAL A 23LYS A 38ILE A 63ASP A 185 | DRK A 384 (-3.8A)NoneNoneDRK A 384 ( 4.5A)DRK A 384 ( 4.7A) | 0.93A | 5yf9X-3eb0A:29.2 | 5yf9X-3eb0A:12.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YWM_X_NIOX403_0 (CASEIN KINASE IISUBUNIT ALPHA') |
3f3z | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE WITH A KINASEDOMAIN AND 4CALMODULIN LIKE EFHANDS (Cryptosporidiumparvum) | 4 / 7 | VAL A 42LYS A 57ILE A 86ILE A 168 | DRK A 1 ( 4.9A)DRK A 1 (-4.1A)DRK A 1 ( 4.8A)DRK A 1 ( 4.2A) | 0.47A | 5ywmX-3f3zA:26.1 | 5ywmX-3f3zA:14.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_A_LEVA801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36GLU A 50MET A 54TYR A 119 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneDRK A 384 (-4.4A) | 0.55A | 5zv2A-3eb0A:20.5 | 5zv2A-3eb0A:12.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_B_LEVB801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 6 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50MET A 54 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneNone | 0.53A | 5zv2B-3eb0A:20.4 | 5zv2B-3eb0A:12.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_B_STIB601_0 (TYROSINE-PROTEINKINASE ABL1) |
3eb0 | PUTATIVEUNCHARACTERIZEDPROTEIN (Cryptosporidiumparvum) | 7 / 12 | LEU A 15VAL A 23ALA A 36LYS A 38GLU A 50MET A 54LEU A 173 | DRK A 384 (-3.8A)NoneDRK A 384 (-3.5A)NoneNoneNoneDRK A 384 (-4.4A) | 0.68A | 6hd6B-3eb0A:20.8 | 6hd6B-3eb0A:13.26 |